Characterization of a transplantable hormone-responsive human prostatic cancer xenograft TEN12 and its androgen-resistant sublines
- 31 October 2003
- journal article
- Published by Wiley in The Prostate
- Vol. 58 (1) , 13-22
- https://doi.org/10.1002/pros.10315
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer CellsJournal of Biological Chemistry, 2002
- Androgens modulate the balance between VEGF and angiopoietin expression in prostate epithelial and smooth muscle cellsThe Prostate, 2002
- TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independenceInternational Journal of Cancer, 2001
- VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION AND TUMOR ANGIOGENESIS ARE REGULATED BY ANDROGENS IN HORMONE RESPONSIVE HUMAN PROSTATE CARCINOMA: : EVIDENCE FOR ANDROGEN DEPENDENT DESTABILIZATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR TRANSCRIPTSJournal of Urology, 2001
- Antisense targeting of basic fibroblast growth factor and dibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growthNature Medicine, 1997
- Epidermal growth factor receptor expression by Northern analysis and immunohistochemistry in benign and malignant prostatic tumoursEuropean Journal Of Cancer, 1995
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995
- In vivo amplification of the androgen receptor gene and progression of human prostate cancerNature Genetics, 1995
- Inhibition of angiogenesis as a strategy for tumor growth controlMolecular and Chemical Neuropathology, 1994
- Site-specific growth of the prostate xenograft line UCRU-PR-2The Prostate, 1989